The deadline on US pharmaceutical tariffs has been dramatically brought forward, in the latest escalation of Donald Trump's ...

Australia’s pharmaceutical benefits scheme is not up for negotiation, says the federal government in the face of ramped-up US ...

President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in ...

President Donald Trump’s tariff strategy is less about trade and more about geopolitical blackmail. By refusing to be rushed ...

Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

The U.S. is Europe and Britain’s largest export market. About 20% of EU exports go to the U.S. at a value of around $581 ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

That's the total value of pharmaceuticals China imported last year, up from $27 billion in 2017. Despite Beijing's drive for economic self-sufficiency, it has continued to welcome U.S. medical ...